WAM
PFE icon

WNY Asset Management’s Pfizer PFE Stock Holding History

WNY Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$690 Buy
+10
New +$247 ﹤0.01% 243

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

WNY Asset Management's PFE Position: Q1 2026 in Review

WNY Asset Management opened a new position in Pfizer (PFE) in Q1 2026: 33,878 shares worth $951K. The stake represents 0.1% of the portfolio and ranks #103 among its holdings. This is a return to the name: WNY Asset Management previously reported a position in PFE as recently as Q3 2025.

WNY Asset Management first reported a position in PFE in Q4 2020 and has held it in 21 quarters since. The position peaked at $3.06M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • WNY Asset Management held 33,878 shares of Pfizer worth $951K as of Q1 2026.
  • Pfizer was a new WNY Asset Management position in Q1 2026.
  • Pfizer made up 0.1% of WNY Asset Management's portfolio in Q1 2026, its #103 holding.
  • WNY Asset Management first reported a position in Pfizer in Q4 2020 and has held it in 21 quarters since.
  • WNY Asset Management's Pfizer position peaked at $3.06M in Q4 2021.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on WNY Asset Management's 13F filing for Q1 2026, filed 22 May 2026.